Zai Lab Limited (NASDAQ: ZLAB) closed the day trading at $25.78 up 0.08% from the previous closing price of $25.76. In other words, the price has increased by $+0.02 from its previous closing price. On the day, 640902 shares were traded. ZLAB stock price reached its highest trading level at $27.98 during the session, while it also had its lowest trading level at $25.73.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
Ratios:
For a better understanding of ZLAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.40 and its Current Ratio is at 7.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on August 10, 2023, initiated with a Overweight rating and assigned the stock a target price of $70.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 when Edmondson Frazor Titus III sold 7,965 shares for $40.55 per share. The transaction valued at 322,981 led to the insider holds 19,400 shares of the business.
Reinhart Harald sold 11,480 shares of ZLAB for $459,200 on Mar 03. The insider now owns 18,958 shares after completing the transaction at $40.00 per share. On Mar 03, another insider, Lis William, who serves as the Director of the company, sold 5,434 shares for $38.31 each. As a result, the insider received 208,177 and left with 23,330 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2.62B and an Enterprise Value of 1.76B. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.11 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 7.01 whereas that against EBITDA is -4.16.
Stock Price History:
Over the past 52 weeks, ZLAB has reached a high of $49.81, while it has fallen to a 52-week low of $20.98. The 50-Day Moving Average of the stock is 26.79, while the 200-Day Moving Average is calculated to be 32.94.
Shares Statistics:
Over the past 3-months, ZLAB traded about 477.05K shares per day on average, while over the past 10 days, ZLAB traded about 496.08k shares per day. A total of 98.84M shares are outstanding, with a floating share count of 96.60M. Insiders hold about 1.30% of the company’s shares, while institutions hold 71.20% stake in the company. Shares short for ZLAB as of Aug 30, 2023 were 3.28M with a Short Ratio of 3.28M, compared to 3.05M on Jul 30, 2023.
Earnings Estimates
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$0.92 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$1.25, while EPS last year was -$1.68. The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.62 and low estimates of -$1.29.
Analysts are recommending an EPS of between -$2.63 and -$4.58 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$2.98, with 9 analysts recommending between -$1.71 and -$4.45.
Revenue Estimates
4 analysts predict $77.78M in revenue for the current quarter. It ranges from a high estimate of $80.8M to a low estimate of $75.7M. As of the current estimate, Zai Lab Limited’s year-ago sales were $57.54M, an estimated increase of 35.20% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $90.63M, an increase of 44.80% over than the figure of $35.20% in the same quarter last year. There is a high estimate of $93.61M for the next quarter, whereas the lowest estimate is $84.7M.
A total of 9 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $304.6M, while the lowest revenue estimate was $288.63M, resulting in an average revenue estimate of $296.85M. In the same quarter a year ago, actual revenue was $215.04M, up 38.00% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $452.41M in the next fiscal year. The high estimate is $500.7M and the low estimate is $401.9M. The average revenue growth estimate for next year is up 52.40% from the average revenue estimate for this year.